Skip to content
akaturk Academic measurement
Sign in Sign up

OpenAlex topic

Dialysis and Renal Disease Management

This page lists works and academicians tagged with an OpenAlex topic. It is not a YÖKSİS primary or secondary field.

OpenAlex 6,356 works 291 author topics

Works

6,356 works

  1. Global kidney health 2017 and beyond: a roadmap for closing gaps in care, research, and policy 2017
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.9%

    No abstract yet.

  2. Mortality and cardiovascular events in online haemodiafiltration OL HDF compared with high flux dialysis results from the Turkish OL HDF Study 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal in patients undergoing maintenance HD. The aim of this study was to compare postdilution OL-HDF and high-flux HD in terms of morbidity and mortality. METHODS: In this prospective,…

  3. Mortality and cardiovascular events in online haemodiafiltration OL HDF compared with high flux dialysis results from the Turkish OL HDF Study 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal in patients undergoing maintenance HD. The aim of this study was to compare postdilution OL-HDF and high-flux HD in terms of morbidity and mortality. METHODS: In this prospective,…

  4. Mortality and cardiovascular events in online haemodiafiltration OL HDF compared with high flux dialysis results from the Turkish OL HDF Study 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal in patients undergoing maintenance HD. The aim of this study was to compare postdilution OL-HDF and high-flux HD in terms of morbidity and mortality. METHODS: In this prospective,…

  5. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis: results from the Turkish OL-HDF Study 2012
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal in patients undergoing maintenance HD. The aim of this study was to compare postdilution OL-HDF and high-flux HD in terms of morbidity and mortality. METHODS: In this prospective,…

  6. Mortality and cardiovascular events in online haemodiafiltration OL HDF compared with high flux dialysis results from the Turkish OL HDF Study 2013
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    BACKGROUND: Online haemodiafiltration (OL-HDF) is considered to confer clinical benefits over haemodialysis (HD) in terms of solute removal in patients undergoing maintenance HD. The aim of this study was to compare postdilution OL-HDF and high-flux HD in terms of morbidity and mortality. METHODS: In this prospective,…

  7. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury 2002
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%

    The cytokine erythropoietin (EPO) possesses potent neuroprotective activity against a variety of potential brain injuries, including transient ischemia and reperfusion. It is currently unknown whether EPO will also ameliorate spinal cord injury. Immunocytochemistry performed using human spinal cord sections showed abu…

  8. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury 2002
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.4%

    The cytokine erythropoietin (EPO) possesses potent neuroprotective activity against a variety of potential brain injuries, including transient ischemia and reperfusion. It is currently unknown whether EPO will also ameliorate spinal cord injury. Immunocytochemistry performed using human spinal cord sections showed abu…

  9. Epidemiology contributors to and clinical trials of mortality risk in chronic kidney failure 2014
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.8%

    No abstract yet.

  10. Complexation and coacervation of polyelectrolytes with oppositely charged colloids 2011
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 98.6%

    No abstract yet.

  11. End stage renal disease atherosclerosis and cardiovascular mortality Is C reactive protein the missing link 2001
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 1% OpenAlex 99.5%

    No abstract yet.

  12. Chronic kidney disease is a key risk factor for severe COVID-19: a call to action by the ERA-EDTA 2021
    YÖKSİS SJR Q1 JCR Q1 OpenAlex top 10% OpenAlex 97.8%

    Diabetes, hypertension and cardiovascular disease have been listed as risk factors for severe coronavirus disease 2019 (COVID-19) since the first report of the disease in January 2020. However, this report did not mention chronic kidney disease (CKD) nor did it provide information on the relevance of estimated glomeru…

Academicians

291 academicians